{
    "medicine_id": "d70b7df4d43df11577a789251cf80006efe4d81a",
    "platform_id": "DB06171",
    "metadata": {
        "name": "Ilaris 150 mg Injection powder for solution",
        "composition": "150 mg Paclitaxel trevatide",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in brain cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "Ouabain may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Digitoxin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "Oleandrin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Cymarin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "Proscillaridin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Metildigoxin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "Lanatoside C may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "Gitoformate may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Acetyldigoxin may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "Peruvoside may decrease the cardiotoxic activities of Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of cardiotoxicity can be increased when Peginterferon alfa 2a is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of cardiotoxicity can be increased when Cladribine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of cardiotoxicity can be increased when Carmustine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of cardiotoxicity can be increased when Amsacrine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitomycin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of cardiotoxicity can be increased when Teniposide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of cardiotoxicity can be increased when Epirubicin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of cardiotoxicity can be increased when Cisplatin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of cardiotoxicity can be increased when Cyclophosphamide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of cardiotoxicity can be increased when Fluorouracil is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of cardiotoxicity can be increased when Pentostatin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of cardiotoxicity can be increased when Methotrexate is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of cardiotoxicity can be increased when Imatinib is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of cardiotoxicity can be increased when Tamoxifen is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of cardiotoxicity can be increased when Daunorubicin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of cardiotoxicity can be increased when Tretinoin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of cardiotoxicity can be increased when Etoposide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mechlorethamine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of cardiotoxicity can be increased when Doxorubicin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of cardiotoxicity can be increased when Thalidomide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of cardiotoxicity can be increased when Fludarabine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of cardiotoxicity can be increased when Capecitabine is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of cardiotoxicity can be increased when Arsenic trioxide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of cardiotoxicity can be increased when Idarubicin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of cardiotoxicity can be increased when Ifosfamide is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The risk or severity of cardiotoxicity can be increased when Anastrozole is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of cardiotoxicity can be increased when Paclitaxel is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of cardiotoxicity can be increased when Docetaxel is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB06013",
                        "description": "The risk or severity of cardiotoxicity can be increased when Aldoxorubicin is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of cardiotoxicity can be increased when Paclitaxel trevatide is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB13809",
                        "description": "The risk or severity of cardiotoxicity can be increased when Paclitaxel trevatide is combined with Paclitaxel poliglumex"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of cardiotoxicity can be increased when Paclitaxel trevatide is combined with Pertuzumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}